Mirum Pharmaceuticals Announces New Rare Liver Disease Data at EASL 2026
Mirum Pharmaceuticals unveiled promising new data on experimental therapies for rare liver diseases at the EASL International Liver Congress 2026, offering hope for patients with limited treatment options. The findings, ... Read More